On October 16th, Smoore International (06969.HK), a listed company on the Hong Kong Stock Exchange, announced that the U.S. Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) to R.J. Reynolds Vapor Company (RJR) regarding six flavors of their Vuse Alto brand e-cigarette products, including mint and mixed berry flavors. Smoore International has been notified by RJR that the temporary administrative stay of the Marketing Denial Order (MDO) has been approved, allowing the marketing and distribution of mint-flavored products to continue in the United States.
Smoore has announced that its board of directors has taken notice of the Marketing Denial Order (MDO) issued by the FDA to R.J. Reynolds Vapor Company (RJR) on October 12, 2023. This order pertains to six e-cigarette products under RJR's Vuse Alto brand, specifically the mint and mixed berry flavors. The company supplies mint-flavored products to RJR, which accounted for approximately 13% of the group's revenue between January 1, 2022, and September 30, 2023.
Smoore has announced that the board has taken note of RJR's intention to question MDOs and seek a temporary stay of execution. The company has also been informed by RJR that the temporary administrative stay for MDOs has been approved, allowing the marketing and distribution of mint-flavored products to continue in the United States. If the temporary stay is granted, mint-flavored products will be able to continue to be marketed and distributed in the United States. However, if RJR fails to obtain the temporary stay and the temporary administrative stay expires or is revoked, or if the MDOs are ultimately upheld, mint-flavored products may not be allowed to be marketed and distributed in the United States.
Smoore has stated that the company will closely monitor the situation and provide further updates as necessary.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
